EVEREST MEDICINES

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark EVEREST MEDICINES was filed as Figurative mark on 06/16/2020 at the World Intellectual Property Organization.

Trademark Details Last update: August 26, 2022

Trademark form Figurative mark
File reference 1568803
Countries Indonesia South Korea Malaysia Philippines Singapore Thailand Vietnam
Base trademark US No. 88584513, August 19, 2019
Application date June 16, 2020
Expiration date June 16, 2030

Trademark owner

66th Floor, Tower 1, Plaza 66
West Nanjing 1266
CN

Trademark representatives

440 Stevens Avenue, Suite 200 Solana Beach CA 92075 US

goods and services

01 Active chemical ingredients for use in the manufacture of anti-cancer drugs; chemical additives for use in the manufacture of medicines; chemical substances for use in the production of drugs
05 Pharmaceuticals, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical preparations for health care, namely, for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; medicated and pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health
42 Pharmaceutical research; research and development of pharmaceuticals; drug development, namely, pharmaceutical drug development services; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines, excluding any use in connection with for-fee services typically provided by clinical research organizations

Trademark history

Date Document number Area Entry
August 24, 2022 2022/34 Gaz MY Rejection
June 13, 2022 2022/24 Gaz KR Rejection
June 10, 2022 2022/24 Gaz TH Rejection
January 4, 2022 2022/1 Gaz VN Rejection
October 21, 2021 2021/42 Gaz ID Rejection
July 2, 2021 2021/26 Gaz SG Rejection
May 23, 2021 2021/21 Gaz PH Rejection
June 16, 2020 2020/52 Gaz US Registration

ID: 141568803